{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:07:16Z","timestamp":1791090436297,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373737"],"award-info":[{"award-number":["82373737"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007054","name":"Second Military Medical University","doi-asserted-by":"publisher","award":["311"],"award-info":[{"award-number":["311"]}],"id":[{"id":"10.13039\/501100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021831","name":"Institute of Microbiology, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejmech.2025.117817","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T19:04:45Z","timestamp":1748459085000},"page":"117817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor"],"prefix":"10.1016","volume":"296","author":[{"given":"Zirui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leimeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5156-6125","authenticated-orcid":false,"given":"Dongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117817_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14787210.2023.2203383","article-title":"The antifungal pipeline for invasive fungal diseases: what does the future hold?","volume":"21","author":"Neoh","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2025.117817_bib2","series-title":"Hum. Fungal Pathog. Identif.","first-page":"17","article-title":"The changing epidemiology of invasive fungal infections","author":"Enoch","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117817_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.4155\/fmc-2016-0124","article-title":"How can we bolster the antifungal drug discovery pipeline?","volume":"8","author":"Jampilek","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib4","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","article-title":"Global incidence and mortality of severe fungal disease","volume":"24","author":"Denning","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2025.117817_bib5","series-title":"WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117817_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ejmech.2025.117817_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.553648","article-title":"A 5-Year review of invasive fungal infection at an academic medical center","volume":"10","author":"Li","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117817_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccm.2017.04.003","article-title":"Overview of treatment approaches for fungal infections","volume":"38","author":"Carmona","year":"2017","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.ejmech.2025.117817_bib9","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1021\/acs.jmedchem.7b01413","article-title":"Emerging new targets for the treatment of resistant fungal infections","volume":"61","author":"Liu","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib10","series-title":"Hum. Fungal Pathog. Identif.","first-page":"107","article-title":"Systemic antifungal agents: current status and projected future developments","author":"Seyedmousavi","year":"2017"},{"key":"10.1016\/j.ejmech.2025.117817_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IDR.S124918","article-title":"Antifungal resistance: current trends and future strategies to combat","volume":"10","author":"Wiederhold","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2025.117817_bib12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib13","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14\u03b1-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.idc.2015.10.012","article-title":"Antifungal agents, infect","volume":"30","author":"Nett","year":"2016","journal-title":"Dis. Clin. North Am."},{"key":"10.1016\/j.ejmech.2025.117817_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tips.2022.10.004","article-title":"Oteseconazole (VIVOJA) for prevention of recurrent vulvovaginal candidiasis","volume":"44","author":"Vanreppelen","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2025.117817_bib16","first-page":"1017","article-title":"Oteseconazole: first approval","volume":"82","author":"Hoy","year":"2022","journal-title":"Drugs (Basel)"},{"key":"10.1016\/j.ejmech.2025.117817_bib17","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1021\/acs.jmedchem.6b01203","article-title":"Tackling fungal resistance by biofilm inhibitors","volume":"60","author":"Wu","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acs.jmedchem.7b01138","article-title":"Alkylated piperazines and piperazine-azole hybrids as antifungal agents","volume":"61","author":"Thamban Chandrika","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jam.14949","article-title":"Biofilm of Candida albicans : formation, regulation and resistance","volume":"131","author":"Pereira","year":"2021","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117817_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw018","article-title":"Pathogenesis of Candida albicans biofilm","volume":"74","author":"Tsui","year":"2016","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.ejmech.2025.117817_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/1040841X.2020.1843400","article-title":"Candida albicans biofilms and polymicrobial interactions","volume":"47","author":"Ponde","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2025.117817_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115658","article-title":"Strategies of targeting CYP51 for IFIs therapy: emerging prospects, opportunities and challenges","volume":"259","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116942","article-title":"Identification of novel and potent triazoles targeting CYP51 for antifungal: design, synthesis, and biological study","volume":"280","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib24","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1016\/j.tetlet.2006.03.199","article-title":"Efficient microwave-assisted synthesis of 1-(1H-indol-1-yl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents","volume":"47","author":"Lebouvier","year":"2006","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2025.117817_bib25","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1021\/acs.jmedchem.5b01979","article-title":"Development and in vitro evaluation of a microbicide gel formulation for a novel non-nucleoside reverse transcriptase inhibitor belonging to the N -dihydroalkyloxybenzyloxopyrimidines (N-DABOs) family","volume":"59","author":"Tintori","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib26","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/jm051211n","article-title":"Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking","volume":"49","author":"Sheng","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116949","article-title":"Discovery of highly potent triazole derivatives with broad-spectrum antifungal activity based on iodiconazole","volume":"280","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1038\/s41467-023-38192-3","article-title":"Chemistry-intuitive explanation of graph neural networks for molecular property prediction with substructure masking","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117817_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","article-title":"ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database","volume":"10","author":"Dong","year":"2018","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2025.117817_bib30","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.117817_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles","volume":"397","author":"Strushkevich","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117817_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113337","article-title":"Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections","volume":"216","author":"Xu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib33","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/nprot.2017.005","article-title":"Antifungal drug testing by combining minimal inhibitory concentration testing with target identification by gas chromatography\u2013mass spectrometry","volume":"12","author":"M\u00fcller","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2025.117817_bib34","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1021\/acs.jmedchem.3c02331","article-title":"Discovery of new tricyclic oxime sampangine derivatives as potent antifungal agents for the treatment of cryptococcosis and candidiasis","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114819","article-title":"Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections","volume":"197","author":"Liu","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2025.117817_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112360","article-title":"Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents","volume":"198","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113715","article-title":"Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives","volume":"224","author":"Zhao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1586\/14787210.7.1.107","article-title":"Trends in antifungal susceptibility testing using CLSI reference and commercial methods","volume":"7","author":"Cant\u00f3n","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2025.117817_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113740","article-title":"Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi","volume":"225","author":"Yin","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117817_bib40","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1021\/acs.jmedchem.1c01991","article-title":"Species-selective targeting of fungal Hsp90: design, synthesis, and evaluation of novel 4,5-Diarylisoxazole derivatives for the combination treatment of azole-resistant candidiasis","volume":"65","author":"Yin","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425005823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:12:01Z","timestamp":1762265521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425005823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0223523425005823"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117817","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a potent, broad-spectrum and in vivo effective deuterated tetrazole CYP51 inhibitor","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117817"}}